Neuroleptic malignant syndrome due to three atypical antipsychotics in a child.
Chungh DS, Kim BN, Cho SC
Division of Child and Adolescent Psychiatry, Department of Psychiatry, Seoul National University Bundang Hospital, Seoul, Korea.
Neuroleptic Malignant Syndrome (NMS) is a rare, potentially fatal and idiosyncratic drug reaction. It is characterized by a sudden loss of body temperature control, renal and respiratory failure, muscle rigidity, loss of consciousness and impairment of autonomic nervous system. Although NMS was previously associated with the use of classical high-potency neuroleptics, cases have started to emerge with atypical neuroleptics. This article discusses the first case of NMS in a child, induced by the use of risperidone, olanzapine and quetiapine.
Published 28 June 2005 in J Psychopharmacol, 19(4): 422-5.
Full-text of this article is available online (may require subscription).
© 2004-2013 Bipolar Research Today. All Rights Reserved.
| 
